{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-1992-N-0049\" and posted_year = 2010 sorted by posted_date descending", "rows": [["FDA-1992-N-0049-0034", "FDA", "FDA-1992-N-0049", "Reference 12 - \"Comment No. LET20, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:41Z", null, 0, 0, "0900006480ab4d30"], ["FDA-1992-N-0049-0031", "FDA", "FDA-1992-N-0049", "Reference 5 - \"International Conference On Harmonisation of Technical Requirements For Registration of Pharmaceuticals For Human Use\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:36Z", null, 0, 0, "0900006480ab48e8"], ["FDA-1992-N-0049-0033", "FDA", "FDA-1992-N-0049", "Reference 11 - \"Comment No. LET19, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:39Z", null, 0, 0, "0900006480ab4d2e"], ["FDA-1992-N-0049-0035", "FDA", "FDA-1992-N-0049", "Reference 13 - \"Comment No. LET21, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:42Z", null, 0, 0, "0900006480ab4d32"], ["FDA-1992-N-0049-0042", "FDA", "FDA-1992-N-0049", "Reference 22 - \"FDA Labeling Cost Model, Final Report\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:53Z", null, 0, 0, "0900006480ab4eaa"], ["FDA-1992-N-0049-0039", "FDA", "FDA-1992-N-0049", "Reference 17 - \"Comment No. C4, NDMA 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:48Z", null, 0, 0, "0900006480ab4d3e"], ["FDA-1992-N-0049-0036", "FDA", "FDA-1992-N-0049", "Reference 14 - \"Comment No. LET22, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:44Z", null, 0, 0, "0900006480ab4d3b"], ["FDA-1992-N-0049-0032", "FDA", "FDA-1992-N-0049", "Reference 10 - \"Comment No. RPT3, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:38Z", null, 0, 0, "0900006480ab4d2c"], ["FDA-1992-N-0049-0040", "FDA", "FDA-1992-N-0049", "Reference 18 - \"Comment No. C1, Target Health Inc., 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:50Z", null, 0, 0, "0900006480ab4d3f"], ["FDA-1992-N-0049-0029", "FDA", "FDA-1992-N-0049", "List of References - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:33Z", null, 0, 0, "0900006480ab488e"], ["FDA-1992-N-0049-0037", "FDA", "FDA-1992-N-0049", "Reference 15 - \"Comment No. RPT4, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:45Z", null, 0, 0, "0900006480ab4d3c"], ["FDA-1992-N-0049-0030", "FDA", "FDA-1992-N-0049", "Reference 3 - \"Comment No. C4, 1981N-114A\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:35Z", null, 0, 0, "0900006480ab48e5"], ["FDA-1992-N-0049-0041", "FDA", "FDA-1992-N-0049", "Reference 21 - \"Comment No. C2, Wholesale Druggists' Association, 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:51Z", null, 0, 0, "0900006480ab4ea5"], ["FDA-1992-N-0049-0038", "FDA", "FDA-1992-N-0049", "Reference 16 - \"Comment No. C3, American Academy of Dermatology\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:47Z", null, 0, 0, "0900006480ab4d3d"], ["FDA-1992-N-0049-0028", "FDA", "FDA-1992-N-0049", "Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-03-04T05:00:00Z", 2010, 3, "2010-03-04T05:00:00Z", null, "2010-03-08T06:09:32Z", null, 0, 0, "0900006480ab4f84"], ["FDA-1992-N-0049-0023", "FDA", "FDA-1992-N-0049", "NDMA (Nonprescription Drug Manufacturers Association - Request for Extension of Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2010-02-25T05:00:00Z", 2010, 2, "2010-02-25T05:00:00Z", null, "2013-07-27T21:29:03Z", null, 0, 0, "090000648052bd03"]], "truncated": false, "filtered_table_rows_count": 16, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1992-N-0049", "p2": "2010"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010", "results": [{"value": "FDA", "label": "FDA", "count": 16, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-1992-N-0049&posted_year=2010", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 14, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010", "results": [{"value": 2010, "label": 2010, "count": 16, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 411.7049160413444, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}